HomeBLISSGVS • NSE
add
Bliss GVS Pharma Ltd
Previous close
₹121.54
Day range
₹121.31 - ₹123.02
Year range
₹92.15 - ₹185.50
Market cap
12.81B INR
Avg Volume
320.00K
P/E ratio
15.29
Dividend yield
0.41%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 1.98B | -0.07% |
Operating expense | 855.08M | 36.65% |
Net income | 155.39M | 269.87% |
Net profit margin | 7.85 | 269.91% |
Earnings per share | — | — |
EBITDA | 204.04M | -25.58% |
Effective tax rate | 28.96% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.13B | 51.96% |
Total assets | 13.01B | 7.16% |
Total liabilities | 2.09B | -0.90% |
Total equity | 10.92B | — |
Shares outstanding | 105.71M | — |
Price to book | 1.22 | — |
Return on assets | — | — |
Return on capital | 2.81% | — |
Cash Flow
Net change in cash
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 155.39M | 269.87% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1984
Website
Employees
831